NDC 76348-693 - Clear Reflection Complexion
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 76348-693
- Package NDCs from labels
- 76348-693-04
- Manufacturer
- RENU LABORATORIES, INC.
- Effective date
- 2021-08-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Clear Reflection Complexion KIT | RENU LABORATORIES, INC. | 2021-08-19 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 76348-693-04 | Clear Reflection Complexion | 112 g in 1 BOTTLE, PLASTIC | LIQUID | 1 g in 112 | 0.56 g in 112g | 1 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| XYCOS PINK COLLAGEN TONER | ADENOSINE, NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a22d5d31-4c3f-651c-e053-2a95a90ae541 | 2020-03-31 | Warnings | 25X51I8RD4 |
| THE SKIN HOUSE ROSE HEAVEN | ADENOSINE, NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a21c097c-82ac-3a21-e053-2995a90a63eb | 2020-03-30 | Warnings | 25X51I8RD4 |
| THE SKIN HOUSE Rose HeavenCream | ADENOSINE, NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a21ba34c-2d2d-8033-e053-2995a90a1d74 | 2020-03-30 | Warnings | 25X51I8RD4 |
| THE SKIN HOUSE ROSE HEAVEN SERUM | ADENOSINE, NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a21c72f8-00ff-0971-e053-2995a90a2f97 | 2020-03-30 | Warnings | 25X51I8RD4 |
| THE SKIN HOUSE Vital BrightCream | NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a21cbf42-482c-2d95-e053-2a95a90a1a48 | 2020-03-30 | Warnings | 25X51I8RD4 |
| THE SKIN HOUSE Vital Bright Emulsion | NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a21d0eba-a96c-72e8-e053-2995a90addfb | 2020-03-30 | Warnings | 25X51I8RD4 |
| THE SKIN HOUSE Vital Bright EyeCream | NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a21d3c87-0a7f-2e15-e053-2a95a90aee69 | 2020-03-30 | Warnings | 25X51I8RD4 |
| THE SKIN HOUSE Vital BrightSerum | NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a21d8184-258f-679e-e053-2995a90ad7c4 | 2020-03-30 | Warnings | 25X51I8RD4 |
| THE SKIN HOUSE Vital Bright Toner | NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a21daae8-98d6-203a-e053-2a95a90aafe5 | 2020-03-30 | Warnings | 25X51I8RD4 |
| Sterile Water | WATER | Baxter Healthcare Company | 8bcf5572-49e1-4302-9522-56f57904cb4a | 2019-12-29 | Warnings, Adverse reactions | 059QF0KO0R |
| Replenix Acne Gly-Sal 2-2 Foaming Cleanser | SALICYLIC ACID | Topiderm, Inc. | 811dbf95-2b39-45c5-99a2-33c3c9d19570 | 2019-12-19 | Warnings | O414PZ4LPZ |
| Renacidin | CITRIC ACID, GLUCONOLACTONE AND MAGNESIUM CARBONATE | United-Guardian, Inc. | 13a9bbba-db21-4cba-991c-5d8afaf2ed74 | 2019-12-17 | Warnings, Adverse reactions | XF417D3PSL |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | e41adb4e-06fb-4141-ba55-50b043f3c9da | 2019-11-19 | XF417D3PSL | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 14445dfd-6041-40cd-a043-3f4da6bcb9c1 | 2019-11-18 | XF417D3PSL | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 2557199a-5f60-49d8-b093-1e0700211243 | 2019-11-18 | XF417D3PSL | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 794f724c-87f0-49c1-9b26-c9e491978313 | 2019-11-18 | XF417D3PSL | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 5c7d3287-883a-459b-9214-074a583c8a59 | 2019-11-18 | XF417D3PSL | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 448a1dc5-7a98-4b2f-82af-4b92de05cfc3 | 2019-11-18 | XF417D3PSL | |
| Gly-Sal 10-2 Pads | SALICYLIC ACID | Topiderm, Inc. | b39e845d-4c40-4f9e-9cb5-a8386f326652 | 2019-10-23 | Warnings | O414PZ4LPZ |
| Gly-Sal 5-2 Pads | SALICYLIC ACID | Topiderm, Inc. | e73bd26c-cdc2-47ab-94e8-3bc49a9b19e8 | 2019-10-22 | Warnings | O414PZ4LPZ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.